IES20180084A2 - Vitamin medicine pyridine-3-formic acid synthesis method - Google Patents

Vitamin medicine pyridine-3-formic acid synthesis method

Info

Publication number
IES20180084A2
IES20180084A2 IES20180084A IES20180084A IES20180084A2 IE S20180084 A2 IES20180084 A2 IE S20180084A2 IE S20180084 A IES20180084 A IE S20180084A IE S20180084 A IES20180084 A IE S20180084A IE S20180084 A2 IES20180084 A2 IE S20180084A2
Authority
IE
Ireland
Prior art keywords
solution
pyridine
washed
added
synthesis method
Prior art date
Application number
IES20180084A
Inventor
Yan Yida
Original Assignee
Chengdu Dong Dian Ai Er Tech Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chengdu Dong Dian Ai Er Tech Co Ltd filed Critical Chengdu Dong Dian Ai Er Tech Co Ltd
Publication of IES20180084A2 publication Critical patent/IES20180084A2/en
Publication of IES86978B2 publication Critical patent/IES86978B2/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79Acids; Esters
    • C07D213/80Acids; Esters in position 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79Acids; Esters
    • C07D213/803Processes of preparation

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Vitamin medicine pyridine-3-formic acid synthesis method, comprises the following steps: 3 mol 2-hydroxy-3-ethyl-4-aminopyridine and 6-7 mol ethylene glycol monobutyl ether were added to the reaction vessel, controlled the stirring speed of 170-190 rpm, raised the temperature of the solution to 60-70 °C, then added 3-4 mol of triethyl antimony in 3-6 times, raised the temperature of the solution to 75-80 V, kept for 50-70 min, precipitated the solid, washed with potassium bromide solution in 6-9 times, merged the filtrate and the washing liquid, the oxalic acid solution was added to adjust the pH to 2-3, the solution temperature is reduced to 5-9 °C, the solid is precipitated, washed with N-dimethylacetamide solution, and washed with the dimethylamine solution, recrystallized in p-cresol solution.
IES20180084A 2017-04-02 2018-03-27 Vitamin medicine pyridine-3-formic acid synthesis method IES86978B2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201710209149.4A CN108239024A (en) 2017-04-02 2017-04-02 A kind of synthetic method of vitamin medicaments Nicotinicum Acidum

Publications (2)

Publication Number Publication Date
IES20180084A2 true IES20180084A2 (en) 2019-04-03
IES86978B2 IES86978B2 (en) 2019-05-01

Family

ID=58744609

Family Applications (1)

Application Number Title Priority Date Filing Date
IES20180084A IES86978B2 (en) 2017-04-02 2018-03-27 Vitamin medicine pyridine-3-formic acid synthesis method

Country Status (4)

Country Link
CN (1) CN108239024A (en)
AU (1) AU2018100412A4 (en)
GB (1) GB201705841D0 (en)
IE (1) IES86978B2 (en)

Also Published As

Publication number Publication date
GB201705841D0 (en) 2017-05-24
CN108239024A (en) 2018-07-03
AU2018100412A4 (en) 2018-05-10
IES86978B2 (en) 2019-05-01

Similar Documents

Publication Publication Date Title
MX360730B (en) Method for producing hydrogels.
CN105543315A (en) Collagen foaming agent, compound modified collagen foaming agent and their preparation methods
JP2016540774A5 (en)
IES20180084A2 (en) Vitamin medicine pyridine-3-formic acid synthesis method
MY182164A (en) Process for producing acetic acid by introducing a lithium compound
MX357865B (en) Efficient processes for large scale preparation of phosphaplatins antitumor agents.
MX385517B (en) IMPROVED PROCESS FOR PREPARING BIODERIVATIVE PROPYLENE GLYCOL.
CN104402711A (en) Synthesis technology of intermediate of anti-asthma drug namely pranlukast
CN104370830A (en) Synthetic method of 5-trifluoromethyl uracil
CN104649866A (en) Safe, reliable and low-cost preparation method of 9-fluorenylmethanol
BR112017017303B8 (en) Method for obtaining high productivity cell clones
CN103665064B (en) One prepares the method for 2,3,4,6-, tetra--oxygen-benzyl-D-galactopyranose
IES20180091A2 (en) Blood circulation diagnosis medication o-sulfonamide benzoic acid synthesis method
IES20180077A2 (en) Medicine intermediates terephthalic acid synthesis method
IES20180088A2 (en) Drugs intermediates 2-ethylhexanoic acid synthesis method
IES20180117A2 (en) Drug synthesis intermediates p-carboxybenzenesulfonic amide synthesis method
CN104073097A (en) Formula and preparation process of transparent and fragrant polyvinyl acetate emulsion paint
CN107382754A (en) A kind of quick high-efficiency synthesis method for preparing mefenamic acid
AU2016102246A4 (en) Levosimendan drug intermediates acetaminophen propiophenone synthesis method
IE20180280U1 (en) Methylchloroperoxybenzoic acid drug intermediates synthesis method
PH12019500134B1 (en) Method and apparatus for producing compound derived from lignocellulose biomass
IE20180290U1 (en) P-aminobenzaldehyde drug intermediates synthesis method
UA110655U (en) METHOD OF PREPARATION OF 4-METHYL-2-CYNAMYLTHYOPYRIMIDINE-6 (1H) -ONE
IE20180288U1 (en) P-methoxphenylacetic acid drug intermediates synthesis method
AU2016102175A4 (en) Selective methylation reagent p-toluene sulfonic acid methyl ester synthesis method